Bavarian Nordic (BVNRY)
(Delayed Data from OTC)
$10.41 USD
+0.02 (0.21%)
Updated Nov 1, 2024 02:13 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BVNRY 10.41 +0.02(0.21%)
Will BVNRY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for BVNRY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BVNRY
Is Bavarian Nordic (BVNRY) Stock Outpacing Its Medical Peers This Year?
Is Bavarian Nordic (BVNRY) a Great Value Stock Right Now?
BVNRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Bavarian Nordic (BVNRY) Stock?
Bavarian Nordic (BVNRY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Are Investors Undervaluing Bavarian Nordic (BVNRY) Right Now?
Other News for BVNRY
First mpox case linked to African outbreak reported in U.K.
Citi Remains a Buy on Bavarian Nordic AS (0DPB)
Bavarian Nordic in pact with UNICEF for 1M mpox shots
U.S. to donate 1M mpox shots to address outbreak in Africa: report
Bavarian Nordic said to have won $63M mpox vaccine contract from U.S.